Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ric M Procyshyn

Showing results (21-30 of 131) with videos related to

Pageof 14
Sort By:
Current Psychiatry Reports|March 30, 2013
Antipsychotic and psychostimulant drug combination therapy in attention deficit/hyperactivity and disruptive behavior disorders: a systematic review of efficacy and tolerabilityDavid Linton, Alasdair M Barr, William G Honer, et al.
Journal of Psychiatry & Neuroscience : JPN|April 25, 2014
Managing ADHD and disruptive behaviour disorders with combination psychostimulant and antipsychotic treatmentDean Elbe, Alasdair M Barr, William G Honer, et al.
Current Neuropharmacology|June 7, 2016
Antipsychotic Induced Dopamine Supersensitivity Psychosis: A Comprehensive ReviewJohn Yin, Alasdair M Barr, Alfredo Ramos-Miguel, et al.
Psychotherapy and Psychosomatics|July 20, 2018
Reversal of Dopamine Supersensitivity as a Mechanism of Action of ClozapineDavid D Kim, Alasdair M Barr, William G Honer, et al.
Molecular Psychiatry|February 10, 2018
Exercise-induced hippocampal neurogenesis: 5-HT<sub>3</sub> receptor antagonism by antipsychotics as a potential limiting factor in SchizophreniaDavid D Kim, Alasdair M Barr, William G Honer, et al.
Journal of Psychiatry & Neuroscience : JPN|April 28, 2016
Breakthrough symptoms after switching long-acting injectable paliperidone palmitate from the gluteal to the deltoid site of administrationRic M Procyshyn, Jan L Banasch, Alasdair M Barr, et al.
Journal of Clinical Psychopharmacology|November 14, 2014
Dimenhydrinate use disorder with chronic psychosisRandall F White, William G Honer, Ric M Procyshyn, et al.
Medical Hypotheses|December 24, 2013
Clozapine administered once versus twice daily: does it make a difference?Ric M Procyshyn, Fidel Vila-Rodriguez, William G Honer, et al.
International Clinical Psychopharmacology|August 2, 2017
Risk of hair loss with different antidepressants: a comparative retrospective cohort studyMahyar Etminan, Mohit Sodhi, Ric M Procyshyn, et al.
Schizophrenia Research|October 24, 2007
Antipsychotic polypharmacy does not increase the risk for side effectsSoma Ganesan, Ross Taylor, Kiran Rabheru, et al.
Pageof 14

Showing results (21-30 of 131) with videos related to

Sort By:
Pageof 14
Current Psychiatry Reports|March 30, 2013
Antipsychotic and psychostimulant drug combination therapy in attention deficit/hyperactivity and disruptive behavior disorders: a systematic review of efficacy and tolerabilityDavid Linton, Alasdair M Barr, William G Honer, et al.
Journal of Psychiatry & Neuroscience : JPN|April 25, 2014
Managing ADHD and disruptive behaviour disorders with combination psychostimulant and antipsychotic treatmentDean Elbe, Alasdair M Barr, William G Honer, et al.
Current Neuropharmacology|June 7, 2016
Antipsychotic Induced Dopamine Supersensitivity Psychosis: A Comprehensive ReviewJohn Yin, Alasdair M Barr, Alfredo Ramos-Miguel, et al.
Psychotherapy and Psychosomatics|July 20, 2018
Reversal of Dopamine Supersensitivity as a Mechanism of Action of ClozapineDavid D Kim, Alasdair M Barr, William G Honer, et al.
Molecular Psychiatry|February 10, 2018
Exercise-induced hippocampal neurogenesis: 5-HT<sub>3</sub> receptor antagonism by antipsychotics as a potential limiting factor in SchizophreniaDavid D Kim, Alasdair M Barr, William G Honer, et al.
Journal of Psychiatry & Neuroscience : JPN|April 28, 2016
Breakthrough symptoms after switching long-acting injectable paliperidone palmitate from the gluteal to the deltoid site of administrationRic M Procyshyn, Jan L Banasch, Alasdair M Barr, et al.
Journal of Clinical Psychopharmacology|November 14, 2014
Dimenhydrinate use disorder with chronic psychosisRandall F White, William G Honer, Ric M Procyshyn, et al.
Medical Hypotheses|December 24, 2013
Clozapine administered once versus twice daily: does it make a difference?Ric M Procyshyn, Fidel Vila-Rodriguez, William G Honer, et al.
International Clinical Psychopharmacology|August 2, 2017
Risk of hair loss with different antidepressants: a comparative retrospective cohort studyMahyar Etminan, Mohit Sodhi, Ric M Procyshyn, et al.
Schizophrenia Research|October 24, 2007
Antipsychotic polypharmacy does not increase the risk for side effectsSoma Ganesan, Ross Taylor, Kiran Rabheru, et al.
Pageof 14